NAD+ (nicotinamide adenine dinucleotide) supplements have exploded in popularity for “longevity” and “anti-aging.” Nad supplements include NMN, NR, niacin, and others. Evidence is preliminary and marketing far outpaces data.
The NAD+ story
NAD+ is essential coenzyme involved in cellular energy and DNA repair. NAD+ levels decline with age. The hypothesis: raising NAD+ might slow aging or related diseases. Animal studies promising; human evidence preliminary.
Common NAD+ precursors
NR (Nicotinamide Riboside):
- Tru Niagen brand
- Some human studies
- Generally raises NAD+ levels
- Long-term outcomes unclear
NMN (Nicotinamide Mononucleotide):
- Heavily marketed for longevity
- FDA recently classified as drug (not supplement) — regulatory status complicated
- Some human studies
- Long-term effects unknown
Niacin (vitamin B3):
- Old, cheap precursor
- Side effects (flushing) at higher doses
- Less popular for “longevity” marketing despite raising NAD+
Current evidence
- NAD+ levels increase with supplementation
- Translation to clinical benefits uncertain
- Animal studies show promising effects on aging-related metrics
- Human longevity outcomes data not available
- Specific conditions (some metabolic) showing some benefit
Marketing vs reality
“Reverse aging” claims are aggressive marketing without strong evidence. Reasonable framing: NAD+ supplementation is interesting research area without proven longevity benefits in humans.
Cost considerations
NMN and NR are expensive ($30-100+/month). Niacin is much cheaper. Whether premium products provide meaningful additional benefit unclear.
Frequently Asked Questions
Will NAD+ supplements extend my life?
No proven longevity benefit in humans yet.
Should I take NMN or NR?
NR has more straightforward regulatory status currently. Both raise NAD+.
Are NAD+ IV infusions effective?
Limited evidence; expensive. Oral precursors achieve similar level increases.
Are NAD+ supplements safe?
Short-term safety appears good. Long-term unknown.
Why is NMN classified as a drug now?
FDA classified NMN as drug due to investigational drug status. Regulatory implications evolving.
The bottom line on NAD+ supplements
Interesting research area; aggressive marketing exceeds evidence. Long-term human benefits unproven. Make purchase decisions accordingly.